Man grabs at his heart. He has a heart attack. risk of heart attacks, heart attack patients, alirocumab

Alirocumab (Praluent) is a cholesterol-lowering drug that works through a different enzyme system than statins. (Here are the technical details: alirocumab and its cousin evolocumab inhibit an enzyme called PCSK9 that keeps the body from getting rid of LDL cholesterol. All of the statins inhibit an enzyme called HMG-coA reductase that creates LDL cholesterol.) When the FDA approved alirocumab in July, 2015, the manufacturer did not have any data on its potential benefits beyond its ability to lower cholesterol.

Does Alirocumab Prevent Heart Attacks?

Now a study published in The New England Journal of Medicine addresses that question (NEJM, online Nov. 7, 2018). The researchers recruited more than 18,000 patients at very high risk of a heart attack. These participants had recently suffered an acute coronary syndrome. In addition, they had elevated cholesterol despite being on a high-dose statin drug.

The volunteers were randomly assigned to get Praluent or placebo injections in addition to their statins. After approximately three years, 3.5 percent of the individuals on alirocumab had died, compared to 4.1 percent of those on placebo. That works out to approximately 6 people in 1,000 who might benefit, provided they are at comparably high risk to those in the study.

Side Effects of Alirocumab:

Side effects in the two groups were similar, although more people getting Praluent had painful injection site reactions. Roughly one in five of the patients with diabetes reported worsening of that condition on placebo as well as on Praluent. Presumably that is explained in large measure by the high dose statins all the volunteers were taking. Roughly one in ten people who did not have diabetes when the study began developed this condition during the course of the trial. Other side effects included memory problems and/or confusion, liver problems and cataracts. These are side effects that have been previously associated with statin drugs. Other known side effects of Praluent such as allergic reactions, muscle pain and muscle spasms were not reported.

The People’s Pharmacy Bottom Line on Praluent:

While this medication is clearly not appropriate for everyone with high cholesterol, it seems to offer some protection for those who have had acute coronary syndrome. People at such extremely high risk of heart attack might benefit, especially if statins have not lowered their cholesterol effectively.

Others may want to wait before signing up for this extra step on lowering cholesterol. We have not seen evidence that alirocumab would save lives in people at moderate risk of heart attacks. Keep in mind that other factors besides cholesterol may also contribute to heart attack risk.

Get The Graedons' Favorite Home Remedies Health Guide for FREE

Join our daily email newsletter with breaking health news, prescription drug information, home remedies AND you'll get a copy of our brand new full-length health guide — for FREE!

  1. Dot

    I have always been reluctant to take any medication that has not been on the market for a long period of time. However, I have been taking Praluent for almost a year now with no side effects. My cholesterol has gone from 365 to 157. I only hope that 10 years from now we do not find Praluent was the cause of something equally terrible. I am unable to take any statin and my cardiologist said I wouldn’t survive unless I brought my cholesterol down. So, for now I am in favor of Praluent.

  2. Laura
    Seattle WA

    My husband is probably considered high risk (over 90% blockage of all 3 cardiac arteries, successful angioplasty and 5 stents last week) but is intolerant of statins. Praluent has been prescribed, and he is doing fine.
    I am seeking information on supplements that may enhance Praluent, or at least have no contra-indications.
    Citrus Bergamot lowered his cholesterol by 10% when on Statins (clinical study showed 9-14% reduction when taken with Statins). I’m trying to figure out if adding this might help him get his numbers down. So far, no sign of further clinical studies, and since this is “just” an organic supplement, unlikely further studies will be done.
    This week, Amarin presented a paper on clinical studies for Vascepa, a pharmaceutical variety of fish oil that may be a Statin killer. Amazing results. What you do think of their announcement?

What Do You Think?

We invite you to share your thoughts with others, but remember that our comment section is a public forum. Please do not use your full first and last name if you want to keep details of your medical history anonymous. A first name and last initial or a pseudonym is acceptable. Advice from other commenters on this website is not a substitute for medical attention. Do not stop any medicine without checking with the prescriber. Stopping medication suddenly could result in serious harm. We expect comments to be civil in tone and language. By commenting, you agree to abide by our commenting policy and website terms & conditions. Comments that do not follow these policies will not be posted. Learn how your comment data is processed.

Your cart

Shipping and discount codes are added at checkout.